's Heeren Loo
- Address
- lock Available on a paid plan
Psychiatry and Psychology: Mental Disorders
’s Heeren Loo is conducting clinical research in psychiatry and psychology focused on mental disorders, with attention to autism spectrum disorder and behaviors that challenge. The studies aim to better understand and improve care for people with complex behavioral and psychiatric needs.
- Evaluating treatment effectiveness for challenging behaviors in individuals with intellectual disability
- Assessing how antipsychotic medicines may influence symptoms and daily functioning
This work helps clarify which approaches may support safer and more effective management of behavioral symptoms in children, adolescents, and other vulnerable groups.
Analytical, Diagnostic and Therapeutic Techniques and Equipment: Therapeutics
Research at this site also covers therapeutics within analytical, diagnostic and therapeutic techniques and equipment, with a focus on improving how treatments are used in real-world care. The trials are designed to refine medication management and support better outcomes for young people receiving psychiatric treatment.
- Testing therapeutic drug monitoring to guide safer use of antipsychotic treatment
- Studying ways to reduce side effects such as weight gain during treatment
These investigations are especially relevant for children and adolescents treated with risperidone or aripiprazole, where balancing benefit and safety is a key concern.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in 's Heeren Loo
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Therapeutic Drug Monitoring in Mitigating Risperidone and Aripiprazole-Induced Weight Gain in Pediatric Autism Spectrum Disorder | Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) | Phase III | Recruiting | Jul 2024 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aripiprazole | 2 | Unknown | 2024-07-16 | 2024-07-16 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.